MSH|^
~\&|ACMELab^2.16.840.1.113883.2.1.8.1.5.999^ISO|CAV^7A4BV^L|cymru.nhs.uk^2.16.840.1.113883.2.
1.8.1.5.200^ISO|NHSWales^RQFW3^L|20190514102527+0200||ORU^R01^ORU
R01|5051095-201905141025|T|2.5.1
_
|||AL
PID|||403281375^^^154^PI~5189214567^^^NHS^NH||Bloggs^Joe^^^Mr||20010328|M|||A B M U Health
Board^One Talbot Gateway^Baglan^Neath port talbot^SA12 7BR|||||||||||||||||||||01
PV1||O||||||||CAR
ORC|OR||||||||||||7A3C7MPAT^^^wales.nhs.uk&7A3&L,M,N^^^^^MH Pathology Dept,
OBR|1||914694928301|B3051^HbA1c (IFCC traceable)|||201803091500|||^ABM: Angharad
Shore||||201803091500|^^Dr Andar Gunneberg|^Gunneberg^Andar^^^Dr||||||201803091500|||C
NTE|1||For monitoring known diabetic patients, please follow NICE guidelines. If not a known
diabetic and the patient is asymptomatic, a second confirmatory sample is required within 2 weeks
(WEDS Guidance). HbA1c is unreliable for diagnostic and monitoring purposes in the context of
several conditions, including some haemoglobinopathies, abnormal haemoglobin levels, chronic renal
failure, recent transfusion, pregnancy, or alcoholism.
OBX|1|NM|B3553^HbA1c (IFCC traceable)||49|mmol/mol|<48|H|||C|||201803091500
OBR|2||914694928301|B0001^Full blood count|||201803091500|||^ABM: Carl Owen||||201803091500|^^Dr
Andar Gunneberg|^Gunneberg^Andar^^^Dr||||||201803091500|||F
TQ1|||||||201803091400|201803091500|S^^^^^^^^Urgent
OBX|1|NM|B0300^White blood cell (WBC) count||3.5|x10\S\9/L|4.0-11.0|L|||F|||201803091500
OBX|2|NM|B0307^Haemoglobin (Hb)||200|g/L|130-180|H|||F|||201803091500
OBX|3|NM|B0314^Platelet (PLT) count||500|x10\S\9/L|150-400|H|||F|||201803091500
OBX|4|NM|B0306^Red blood cell (RBC) count||6.00|x10\S\12/L|4.50-6.00|N|||F|||201803091500
OBX|5|NM|B0308^Haematocrit (Hct)||0.60|L/L|0.40-0.52|H|||F|||201803091500
OBX|6|NM|B0309^Mean cell volume (MCV)||120|fL|80-100|H|||F|||201803091500
OBX|7|NM|B0310^Mean cell haemoglobin (MCH)||34.0|pg|27.0-33.0|H|||F|||201803091500
SPM|1|^9146949283||BLOO^Blood^ACME|||||||||||||201803091400|201803091500